Diazoxide choline controlled-release for Prader-Willi syndrome – first line
NIHR HSRIC
Record ID 32016001033
English
Authors' recommendations:
Diazoxide choline is a new drug to treat Prader-Willi syndrome. Prader-Willi syndrome is a rare genetic disorder that causes people to eat uncontrollably and become obese. It may also cause learning difficulties and behavioural problems. Diazoxide choline is a slow release tablet that is taken by mouth. Some studies have suggested that diazoxide choline may help people with Prader-Willi syndrome to control their eating.
Details
Project Status:
Completed
Year Published:
2016
URL for published report:
http://www.hsric.nihr.ac.uk/topics/diazoxide-choline-controlled-release-for-prader-willi-syndrome-first-line/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Humans
- Choline
- Chromosomes, Human, Pair 15
- Delayed-Action Preparations
- Diazoxide
- Prader-Willi Syndrome
Contact
Organisation Name:
NIHR Horizon Scanning Centre
Contact Address:
The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health and Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831, Fax: +44 121 2269
Contact Name:
c.packer@bham.ac.uk
Contact Email:
c.packer@bham.ac.uk
Copyright:
NIHR Horizon Scanning Research&Intelligence Centre (NIHR HSRIC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.